Parkinson's disease (PD) is a neurodegenerative disorder that predominantly affects dopamine-producing neurons in the substantia nigra, a region of the brain. It is the second most common neurodegenerative disorder after Alzheimer's disease, impacting millions worldwide. This article aims to provide a comprehensive overview of PD for healthcare professionals.
The exact cause of PD is unknown, but it is thought to result from a complex interplay of genetic and environmental factors. The hallmark pathological feature is the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to striatal dopamine deficiency. This results in motor symptoms such as bradykinesia, rigidity, and resting tremor.
PD typically presents in the sixth decade of life or later. The cardinal motor symptoms are resting tremor, bradykinesia, and rigidity. Non-motor symptoms such as autonomic dysfunction, cognitive impairment, and mood disorders often precede the motor symptoms and can significantly impact quality of life.
There is no definitive diagnostic test for PD. Diagnosis is primarily clinical, based on history and neurological examination. Imaging, such as DaTscan, can support the diagnosis. Management of PD is symptomatic, with levodopa being the most effective medication for motor symptoms. Non-pharmacological interventions, including physical therapy and exercise, also play a crucial role.
PD is a progressive disorder. The rate of progression varies widely among individuals. Factors associated with faster progression include older age at onset, presence of postural instability and gait difficulty, and cognitive impairment. Despite advances in treatment, PD remains a leading cause of disability.
Understanding the complexities of Parkinson's disease is crucial for healthcare professionals. As we continue to unravel the mysteries of this disorder, we can hope to improve diagnosis, management, and ultimately, patient outcomes. Continued research and education are key to achieving these goals.
1.
According to the Lancet, having cancer and VTE at the same time increases mortality risk.
2.
Pooled Cord Blood Transplants Achieve Near-Perfect Results in Early Trial
3.
Experts say oncology, primary care coordination necessary for best cancer patient outcomes
4.
Urinary tract cancer prediction models with high sensitivity and specificity
5.
New guidelines for radiation therapy for HPV-associated head and neck cancer
1.
The Importance of Early Detection in Skin Cancer: Why Regular Skin Exams Matter
2.
Clinical Frameworks in Hematology for Better Care
3.
Bridging Disciplines: Medical Oncology vs Surgical Oncology in the Era of Multidisciplinary Cancer Care
4.
Unveiling the Hidden Mechanisms of Hemolytic Reactions
5.
Practical Applications in Hematology Across Clinical Settings
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
2.
Thromboprophylaxis In Medical Settings- An Update
3.
Recognizing Symptoms That May Require Cancer Evaluation
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Recognizing the Signs of Anemia in Adults
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation